• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 SARS-CoV-2 的德尔塔变体中,刺突蛋白 P681R 和 D950N 促进膜融合,刺突蛋白 P681R 增强了刺突蛋白的切割,但这两种突变都不影响病毒在仓鼠中的致病性。

In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters.

机构信息

Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.

Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.

出版信息

EBioMedicine. 2023 May;91:104561. doi: 10.1016/j.ebiom.2023.104561. Epub 2023 Apr 10.

DOI:10.1016/j.ebiom.2023.104561
PMID:37043872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10083686/
Abstract

BACKGROUND

The SARS-CoV-2 delta (B.1.617.2 lineage) variant was first identified at the end of 2020 and possessed two unique amino acid substitutions in its spike protein: S-P681R, at the S1/S2 cleavage site, and S-D950N, in the HR1 of the S2 subunit. However, the roles of these substitutions in virus phenotypes have not been fully characterized.

METHODS

We used reverse genetics to generate Wuhan-D614G viruses with these substitutions and delta viruses lacking these substitutions and explored how these changes affected their viral characteristics in vitro and in vivo.

FINDINGS

S-P681R enhanced spike cleavage and membrane fusion, whereas S-D950N slightly promoted membrane fusion. Although S-681R reduced the virus replicative ability especially in VeroE6 cells, neither substitution affected virus replication in Calu-3 cells and hamsters. The pathogenicity of all recombinant viruses tested in hamsters was slightly but not significantly affected.

INTERPRETATION

Our observations suggest that the S-P681R and S-D950N substitutions alone do not increase virus pathogenicity, despite of their enhancement of spike cleavage or fusogenicity.

FUNDING

A full list of funding bodies that contributed to this study can be found under Acknowledgments.

摘要

背景

SARS-CoV-2 德尔塔(B.1.617.2 谱系)变异株于 2020 年底首次被发现,其刺突蛋白上有两个独特的氨基酸取代:S1/S2 裂解位点的 S-P681R 和 S2 亚基 HR1 中的 S-D950N。然而,这些取代在病毒表型中的作用尚未完全阐明。

方法

我们使用反向遗传学方法生成了具有这些取代的武汉-D614G 病毒和缺乏这些取代的德尔塔病毒,并探讨了这些变化如何影响它们在体外和体内的病毒特征。

结果

S-P681R 增强了刺突蛋白的切割和膜融合,而 S-D950N 则略微促进了膜融合。尽管 S-681R 降低了病毒的复制能力,特别是在 VeroE6 细胞中,但这两种取代都没有影响病毒在 Calu-3 细胞和仓鼠中的复制。在仓鼠中测试的所有重组病毒的致病性都略有但无显著影响。

解释

我们的观察结果表明,尽管 S-P681R 和 S-D950N 取代增强了刺突蛋白的切割或融合性,但它们单独作用并不会增加病毒的致病性。

资助

可在致谢中找到为本研究做出贡献的全部资助机构的列表。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/2f4d78a2eca2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/5154c2a8f177/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/5337b35bdcc1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/b6611a7502b3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/2f4d78a2eca2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/5154c2a8f177/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/5337b35bdcc1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/b6611a7502b3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7496/10119705/2f4d78a2eca2/gr4.jpg

相似文献

1
In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters.在 SARS-CoV-2 的德尔塔变体中,刺突蛋白 P681R 和 D950N 促进膜融合,刺突蛋白 P681R 增强了刺突蛋白的切割,但这两种突变都不影响病毒在仓鼠中的致病性。
EBioMedicine. 2023 May;91:104561. doi: 10.1016/j.ebiom.2023.104561. Epub 2023 Apr 10.
2
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.SARS-CoV-2 Delta 突变株 P681R 增强了融合性和致病性。
Nature. 2022 Feb;602(7896):300-306. doi: 10.1038/s41586-021-04266-9. Epub 2021 Nov 25.
3
Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.SARS-CoV-2 P681R 突变体中刺突蛋白的切割激活:从首次在乌干达发现的 A.23.1 谱系中分析。
Microbiol Spectr. 2022 Aug 31;10(4):e0151422. doi: 10.1128/spectrum.01514-22. Epub 2022 Jun 29.
4
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.德尔塔刺突 P681R 突变增强了 SARS-CoV-2 对阿尔法变体的适应能力。
Cell Rep. 2022 May 17;39(7):110829. doi: 10.1016/j.celrep.2022.110829. Epub 2022 Apr 29.
5
Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.SARS-CoV-2 变异株 Alpha、Delta、Omicron 中的内在 D614G 和 P681R/H 突变,以及 Spike 蛋白中具有 D614G 加关键特征性突变的病毒,改变了融合性和感染性。
Med Microbiol Immunol. 2023 Feb;212(1):103-122. doi: 10.1007/s00430-022-00760-7. Epub 2022 Dec 30.
6
Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda.由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)P681R突变介导的刺突蛋白切割激活:来自在乌干达发现的感兴趣变体(VOI)A.23.1中首次出现的案例研究。
bioRxiv. 2022 Mar 28:2021.06.30.450632. doi: 10.1101/2021.06.30.450632.
7
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.刺突蛋白稳定的 D614G 突变与 S1/S2 裂解位点突变相互作用,促进 SARS-CoV-2 变体的感染潜力。
J Virol. 2022 Oct 12;96(19):e0130122. doi: 10.1128/jvi.01301-22. Epub 2022 Sep 19.
8
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.德尔塔毒株刺突蛋白P681R突变增强了严重急性呼吸综合征冠状病毒2相对于阿尔法毒株的适应性。
bioRxiv. 2021 Sep 5:2021.08.12.456173. doi: 10.1101/2021.08.12.456173.
9
SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.SARS-CoV-2 携带 S1/S2 裂解位点突变表现出毒力减弱,并赋予保护性免疫。
mBio. 2021 Aug 31;12(4):e0141521. doi: 10.1128/mBio.01415-21. Epub 2021 Aug 24.
10
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.SARS-CoV-2 刺突蛋白 D614G 取代增加合胞体形成和病毒滴度通过增强的弗林蛋白酶介导的刺突裂解。
mBio. 2021 Aug 31;12(4):e0058721. doi: 10.1128/mBio.00587-21. Epub 2021 Jul 27.

引用本文的文献

1
Critical amino acid residues in human ACE2 for SARS-CoV-2 spike protein binding and virus entry.人ACE2中与SARS-CoV-2刺突蛋白结合及病毒进入相关的关键氨基酸残基。
Microbiol Spectr. 2025 Jun 20:e0324424. doi: 10.1128/spectrum.03244-24.
2
Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入机制的受体结合:来自原始毒株和新出现变体的见解
Viruses. 2025 May 10;17(5):691. doi: 10.3390/v17050691.
3
Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models.
多种新冠病毒变异株在小鼠模型中的致病性比较。
Animal Model Exp Med. 2025 Jul;8(7):1302-1312. doi: 10.1002/ame2.70029. Epub 2025 May 20.
4
Pathogenesis and transmission of SARS-CoV-2 D614G, Alpha, Gamma, Delta, and Omicron variants in golden hamsters.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)D614G、阿尔法、伽马、德尔塔和奥密克戎变异株在金黄地鼠中的发病机制与传播
Npj Viruses. 2025 Feb 24;3(1):15. doi: 10.1038/s44298-025-00092-2.
5
Structural and Conformational Impact of Deleterious Spike Protein Mutations in SARS-CoV-2 Omicron Lineages.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎谱系中有害刺突蛋白突变的结构和构象影响
bioRxiv. 2025 Feb 27:2025.02.25.639252. doi: 10.1101/2025.02.25.639252.
6
A comprehensive review of current insights into the virulence factors of SARS-CoV-2.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)毒力因子当前见解的全面综述。
J Virol. 2025 Feb 25;99(2):e0204924. doi: 10.1128/jvi.02049-24. Epub 2025 Jan 29.
7
An orally available P1'-5-fluorinated M inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.一种口服可用的P1'-5-氟代M抑制剂可在无增强剂的情况下阻断新型冠状病毒复制,并具有高遗传屏障。
PNAS Nexus. 2025 Jan 7;4(1):pgae578. doi: 10.1093/pnasnexus/pgae578. eCollection 2025 Jan.
8
Profiling endogenous airway proteases and antiproteases and modeling proteolytic activation of Influenza HA using in vitro and ex vivo human airway surface liquid samples.使用体外和离体人呼吸道表面液体样本分析内源性气道蛋白酶和抗蛋白酶,并模拟流感血凝素的蛋白水解激活。
PLoS One. 2024 Dec 31;19(12):e0306197. doi: 10.1371/journal.pone.0306197. eCollection 2024.
9
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的持续进化导致其逃避mRNA疫苗诱导的体液免疫。
Cell Rep Med. 2024 Dec 17;5(12):101850. doi: 10.1016/j.xcrm.2024.101850. Epub 2024 Dec 9.
10
Spatiotemporal evolution and transmission dynamics of Alpha and Delta SARS-CoV-2 variants contributing to sequential outbreaks in Cambodia during 2021.2021年期间,导致柬埔寨连续疫情爆发的新冠病毒阿尔法和德尔塔变异株的时空演变及传播动态
Commun Med (Lond). 2024 Nov 28;4(1):252. doi: 10.1038/s43856-024-00685-7.